Related Experiment Video
Updated: May 20, 2026

Reprogramming Pancreatic Ductal Adenocarcinoma to Pluripotency
Published on: February 2, 2024
Generating pluripotent stem cells: differential epigenetic changes during cellular reprogramming
1Cancer Biology and Genetics Program, Center for Cell Engineering, Sloan-Kettering Institute, Gerstner Sloan-Kettering Graduate School of Biomedical Sciences, Weill Medical College of Cornell University, 1275 York Avenue, Box #484, New York, NY 10065, United States.
Induced pluripotent stem cells (iPSCs) offer ethical and histocompatible alternatives for regenerative medicine. However, genetic and epigenetic variations in iPSCs currently limit their clinical applications.
Area of Science:
- Stem cell biology
- Regenerative medicine
- Cellular reprogramming
Background:
- Pluripotent stem cells are crucial for tissue replacement therapies.
- Ethical and histocompatibility issues arise with embryonic and oocyte-derived stem cells.
- Induced pluripotent stem cells (iPSCs) address some of these concerns.
Purpose of the Study:
- To discuss the unique characteristics of iPSCs.
- To explore methods for overcoming iPSC limitations.
- To enhance the clinical utility of iPSCs.
Main Methods:
- Reprogramming somatic cells using ectopic expression of four factors.
- Analysis of genetic and epigenetic differences in iPSCs.
- Review of current approaches to improve iPSC differentiation and safety.
Main Results:
- iPSCs present ethical and histocompatibility advantages over other pluripotent stem cells.
- Genetic and epigenetic variations in iPSCs impact their differentiation potential and functionality.
- Ongoing research aims to mitigate these iPSC-specific limitations.
Conclusions:
- iPSCs hold significant therapeutic promise but require further optimization.
- Addressing genetic and epigenetic disparities is key to unlocking the full clinical potential of iPSCs.
- Future research will focus on enhancing iPSC safety, efficacy, and broad applicability in regenerative medicine.
More Related Videos
10:32Cell Surface Marker Mediated Purification of iPS Cell Intermediates from a Reprogrammable Mouse Model
Published on: September 6, 2014
09:07Chemical Reversion of Conventional Human Pluripotent Stem Cells to a Naïve-like State with Improved Multilineage Differentiation Potency
Published on: June 10, 2018
Related Concept Videos
Somatic to iPS Cell Reprogramming
Chromatin Modification in iPS Cells
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
Methods of Nuclear Reprogramming
Induced Pluripotent Stem Cells
Induced Pluripotent Stem Cells
Induced Pluripotent Stem Cells
Somatic cells are...